About IMAT

The Innovative Molecular Analysis Technologies (IMAT) program was established to support the development, technical maturation, and dissemination of novel and potentially transformative next-generation technologies through an approach of balanced but targeted innovation. In support of its mission, the IMAT program utilizes a variety of investigator-initiated research project grant mechanisms while retaining a strong commitment to diversity and to the training of scientists and clinicians in cross-cutting, research-enabling disciplines.

Please select a link below to learn more about IMAT. 



Recent News & Upcoming Events

Transgenomic has announced that it has licensed a high-sensitivity mutation detection technology called Cold-PCR from the Dana-Farber Cancer Institute (DFCI) in Boston.

...

RiboMed Biotechnologies, Inc. recently announced the receipt of a $150,000 Phase I contract from the National Cancer Institute (NCI) to develop bisulfite-free, DNA methylation...

Two IMAT investigators who have developed specific technologies through the program have continued to succeed in leveraging those technologies to meet scientific needs and...

NIH has restructured the application instructions and forms beginning on January 2010. These guidelines apply to all IMAT Funding Opportunities for 2010. As described on ...

Pages